메뉴 건너뛰기




Volumn 38, Issue 2, 2017, Pages 160-168

Pharmacological Chaperoning: A Potential Treatment for PMM2-CDG

Author keywords

CDG; misfolding proteins; pharmacological chaperones; PMM2

Indexed keywords

1(3 CHLOROPHENYL) 3,3 BIS (PYRIDIN 2 YL)UREA; 2 BROMO N [2 (4 CHLOROPHENYL)ETHYL]BENZAMIDE; 2 [5 (5 BROMO 2 OXO 1,2 DIHYDRO 3J INDOL 3 YLIDENE) 4 OXO 2 THIOXO 1,3 THIAZOLIDIN 3 YL] 4 (METHYLSULFANYL)BUTANOIC ACID; 3 [5 3 [(4 CHOROPHENYL)AMINO] 2 CYANO 3 OXOPROP 1 EN 1 YL]FURAN 2 YL]BENZOIC ACID; 4 AMINO 5 (1H BENZIMIDAZOL 2 YL) 3 PHENYL 1,3 THIAZOLE 2 THIONE; 5 [[1 [2 (2 FLUOROPHENOXY)ETHYL]INDOL 3 YL]METHYLIDINE] 2 SULFANYLIDENE 1,3 THIAZOLIDIN 4 ONE; CHAPERONE; N (4 OXO 2 THIOXO 1,3 DIHYDROQUINAZOLIN 3 YL)ACETAMIDE; N (FURAN 2 YLMETHYL) 6 IMINO 2 OXO 7 PROPYL 1,7,9 TRIAZATRICYCLO[8.4.0.0 (3,8)]TETRADECA 3(8)4,9,11,13 PENTAENE 5 CARBOXAMIDE; PHOSPHOMANNOMUTASE; UNCLASSIFIED DRUG; HYBRID PROTEIN; MUTASE; PHOSPHOMANNOMUTASE 2, HUMAN;

EID: 85006097765     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.23138     Document Type: Article
Times cited : (41)

References (47)
  • 1
    • 84908398480 scopus 로고    scopus 로고
    • Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation
    • Andreotti G, Pedone E, Giordano A, Cubellis MV. 2013. Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation. Mol Genet Genomic Med 1:32–44.
    • (2013) Mol Genet Genomic Med , vol.1 , pp. 32-44
    • Andreotti, G.1    Pedone, E.2    Giordano, A.3    Cubellis, M.V.4
  • 2
    • 84900131626 scopus 로고    scopus 로고
    • Pharmacological chaperones for enzyme enhancement therapy in genetic diseases
    • Aymami J, Barril X, Rodriguez-Pascau L, Martinell M. 2013. Pharmacological chaperones for enzyme enhancement therapy in genetic diseases. Pharm Pat Anal 2:109–124.
    • (2013) Pharm Pat Anal , vol.2 , pp. 109-124
    • Aymami, J.1    Barril, X.2    Rodriguez-Pascau, L.3    Martinell, M.4
  • 3
    • 84908530414 scopus 로고    scopus 로고
    • Chemistry: Chemical con artists foil drug discovery
    • Baell J, Walters MA. 2014. Chemistry: Chemical con artists foil drug discovery. Nature 513:481–483.
    • (2014) Nature , vol.513 , pp. 481-483
    • Baell, J.1    Walters, M.A.2
  • 4
    • 77950571108 scopus 로고    scopus 로고
    • New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays
    • Baell JB, Holloway GA. 2010. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53:2719–2740.
    • (2010) J Med Chem , vol.53 , pp. 2719-2740
    • Baell, J.B.1    Holloway, G.A.2
  • 5
    • 33846078171 scopus 로고    scopus 로고
    • Identification and evaluation of molecular properties related to preclinical optimization and clinical fate
    • Blake JF. 2005. Identification and evaluation of molecular properties related to preclinical optimization and clinical fate. Med Chem 1:649–655.
    • (2005) Med Chem , vol.1 , pp. 649-655
    • Blake, J.F.1
  • 6
    • 0017184389 scopus 로고
    • A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
    • Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254.
    • (1976) Anal Biochem , vol.72 , pp. 248-254
    • Bradford, M.M.1
  • 8
    • 84862023493 scopus 로고    scopus 로고
    • Chemical and biological properties of frequent screening hits
    • Che J, King FJ, Zhou B, Zhou Y. 2012. Chemical and biological properties of frequent screening hits. J Chem Inf Model 52:913–926.
    • (2012) J Chem Inf Model , vol.52 , pp. 913-926
    • Che, J.1    King, F.J.2    Zhou, B.3    Zhou, Y.4
  • 9
    • 84924692170 scopus 로고    scopus 로고
    • PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS
    • Dahlin JL, Nissink JW, Strasser JM, Francis S, Higgins L, Zhou H, Zhang Z, Walters MA. 2015. PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS. J Med Chem 58:2091–2113.
    • (2015) J Med Chem , vol.58 , pp. 2091-2113
    • Dahlin, J.L.1    Nissink, J.W.2    Strasser, J.M.3    Francis, S.4    Higgins, L.5    Zhou, H.6    Zhang, Z.7    Walters, M.A.8
  • 10
    • 84906764097 scopus 로고    scopus 로고
    • The essential roles of chemistry in high-throughput screening triage
    • Dahlin JL, Walters MA. 2014. The essential roles of chemistry in high-throughput screening triage. Future Med Chem 6:1265–1290.
    • (2014) Future Med Chem , vol.6 , pp. 1265-1290
    • Dahlin, J.L.1    Walters, M.A.2
  • 12
    • 0036895451 scopus 로고    scopus 로고
    • Enzyme replacement and enhancement therapies: lessons from lysosomal disorders
    • Desnick RJ, Schuchman EH. 2002. Enzyme replacement and enhancement therapies: lessons from lysosomal disorders. Nat Rev Genet 3:954–966.
    • (2002) Nat Rev Genet , vol.3 , pp. 954-966
    • Desnick, R.J.1    Schuchman, E.H.2
  • 13
    • 37349013379 scopus 로고    scopus 로고
    • A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity
    • Fan JQ. 2008. A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity. Biol Chem 389:1–11.
    • (2008) Biol Chem , vol.389 , pp. 1-11
    • Fan, J.Q.1
  • 14
    • 70249111204 scopus 로고    scopus 로고
    • Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients
    • Freeze HH. 2009. Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients. Biochim Biophys Acta 1792:835–840.
    • (2009) Biochim Biophys Acta , vol.1792 , pp. 835-840
    • Freeze, H.H.1
  • 15
    • 84893734160 scopus 로고    scopus 로고
    • Solving glycosylation disorders: fundamental approaches reveal complicated pathways
    • Freeze HH, Chong JX, Bamshad MJ, Ng BG. 2014. Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am J Hum Genet 94:161–175.
    • (2014) Am J Hum Genet , vol.94 , pp. 161-175
    • Freeze, H.H.1    Chong, J.X.2    Bamshad, M.J.3    Ng, B.G.4
  • 16
    • 84871650725 scopus 로고    scopus 로고
    • Small molecules that target protein misfolding
    • Gavrin LK, Denny RA, Saiah E. 2012. Small molecules that target protein misfolding. J Med Chem 55:10823–10843.
    • (2012) J Med Chem , vol.55 , pp. 10823-10843
    • Gavrin, L.K.1    Denny, R.A.2    Saiah, E.3
  • 17
    • 70349089028 scopus 로고    scopus 로고
    • The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia)
    • Grunewald S. 2009. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). Biochim Biophys Acta 1792:827–834.
    • (2009) Biochim Biophys Acta , vol.1792 , pp. 827-834
    • Grunewald, S.1
  • 18
    • 0035125320 scopus 로고    scopus 로고
    • High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency)
    • Grunewald S, Schollen E, Van Schaftingen E, Jaeken J, Matthijs G. 2001. High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency). Am J Hum Genet 68:347–354.
    • (2001) Am J Hum Genet , vol.68 , pp. 347-354
    • Grunewald, S.1    Schollen, E.2    Van Schaftingen, E.3    Jaeken, J.4    Matthijs, G.5
  • 21
    • 78650401291 scopus 로고    scopus 로고
    • Congenital disorders of glycosylation
    • Jaeken J. 2010. Congenital disorders of glycosylation. Ann NY Acad Sci 1214:190–198.
    • (2010) Ann NY Acad Sci , vol.1214 , pp. 190-198
    • Jaeken, J.1
  • 23
    • 34547697475 scopus 로고    scopus 로고
    • Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study
    • Levy HL, Milanowski A, Chakrapani A, Cleary M, Lee P, Trefz FK, Whitley CB, Feillet F, Feigenbaum AS, Bebchuk JD et al. 2007. Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study. Lancet 370:504–510.
    • (2007) Lancet , vol.370 , pp. 504-510
    • Levy, H.L.1    Milanowski, A.2    Chakrapani, A.3    Cleary, M.4    Lee, P.5    Trefz, F.K.6    Whitley, C.B.7    Feillet, F.8    Feigenbaum, A.S.9    Bebchuk, J.D.10
  • 25
    • 50249175120 scopus 로고    scopus 로고
    • Chemical and biological approaches synergize to ameliorate protein-folding diseases
    • Mu TW, Ong DS, Wang YJ, Balch WE, Yates JR, 3rd, Segatori L, Kelly JW. 2008. Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell 134:769–781.
    • (2008) Cell , vol.134 , pp. 769-781
    • Mu, T.W.1    Ong, D.S.2    Wang, Y.J.3    Balch, W.E.4    Yates, J.R.5    Segatori, S.L.6    Kelly, J.W.7
  • 26
    • 84904099631 scopus 로고    scopus 로고
    • Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators
    • Muntau AC, Leandro J, Staudigl M, Mayer F, Gersting SW. 2014. Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators. J Inherit Metab Dis 37:505–523.
    • (2014) J Inherit Metab Dis , vol.37 , pp. 505-523
    • Muntau, A.C.1    Leandro, J.2    Staudigl, M.3    Mayer, F.4    Gersting, S.W.5
  • 27
    • 37249005205 scopus 로고    scopus 로고
    • The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
    • Niesen FH, Berglund H, Vedadi M. 2007. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc 2:2212–2221.
    • (2007) Nat Protoc , vol.2 , pp. 2212-2221
    • Niesen, F.H.1    Berglund, H.2    Vedadi, M.3
  • 28
    • 0012286670 scopus 로고    scopus 로고
    • Pharmacokinetically based mapping device for chemical space navigation
    • Oprea TI, Zamora I, Ungell AL. 2002. Pharmacokinetically based mapping device for chemical space navigation. J Comb Chem 4:258–266.
    • (2002) J Comb Chem , vol.4 , pp. 258-266
    • Oprea, T.I.1    Zamora, I.2    Ungell, A.L.3
  • 29
    • 84906248420 scopus 로고    scopus 로고
    • Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development
    • Panicker LM, Miller D, Awad O, Bose V, Lun Y, Park TS, Zambidis ET, Sgambato JA, Feldman RA. 2014. Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development. Stem Cells 32:2338–2349.
    • (2014) Stem Cells , vol.32 , pp. 2338-2349
    • Panicker, L.M.1    Miller, D.2    Awad, O.3    Bose, V.4    Lun, Y.5    Park, T.S.6    Zambidis, E.T.7    Sgambato, J.A.8    Feldman, R.A.9
  • 30
    • 84904705105 scopus 로고    scopus 로고
    • The molecular landscape of phosphomannose mutase deficiency in iberian peninsula: identification of 15 population-specific mutations
    • Perez B, Briones P, Quelhas D, Artuch R, Vega AI, Quintana E, Gort L, Ecay MJ, Matthijs G, Ugarte M et al. 2011. The molecular landscape of phosphomannose mutase deficiency in iberian peninsula: identification of 15 population-specific mutations. JIMD Rep 1:117–123.
    • (2011) JIMD Rep , vol.1 , pp. 117-123
    • Perez, B.1    Briones, P.2    Quelhas, D.3    Artuch, R.4    Vega, A.I.5    Quintana, E.6    Gort, L.7    Ecay, M.J.8    Matthijs, G.9    Ugarte, M.10
  • 31
    • 0037242342 scopus 로고    scopus 로고
    • Phenylketonuria: genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH
    • Pey AL, Desviat LR, Gamez A, Ugarte M, Perez B. 2003. Phenylketonuria: genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH. Hum Mutat 21:370–378.
    • (2003) Hum Mutat , vol.21 , pp. 370-378
    • Pey, A.L.1    Desviat, L.R.2    Gamez, A.3    Ugarte, M.4    Perez, B.5
  • 35
    • 0034082327 scopus 로고    scopus 로고
    • Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia)
    • Schollen E, Kjaergaard S, Legius E, Schwartz M, Matthijs G. 2000. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia). Eur J Hum Genet 8:367–371.
    • (2000) Eur J Hum Genet , vol.8 , pp. 367-371
    • Schollen, E.1    Kjaergaard, S.2    Legius, E.3    Schwartz, M.4    Matthijs, G.5
  • 37
    • 80655144748 scopus 로고    scopus 로고
    • Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts
    • Sharma V, Ichikawa M, He P, Scott DA, Bravo Y, Dahl R, Ng BG, Cosford ND, Freeze HH. 2011. Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts. J Biol Chem 286:39431–39438.
    • (2011) J Biol Chem , vol.286 , pp. 39431-39438
    • Sharma, V.1    Ichikawa, M.2    He, P.3    Scott, D.A.4    Bravo, Y.5    Dahl, R.6    Ng, B.G.7    Cosford, N.D.8    Freeze, H.H.9
  • 38
    • 84891837451 scopus 로고    scopus 로고
    • The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine
    • Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. 2014. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133:1–9.
    • (2014) Hum Genet , vol.133 , pp. 1-9
    • Stenson, P.D.1    Mort, M.2    Ball, E.V.3    Shaw, K.4    Phillips, A.5    Cooper, D.N.6
  • 39
    • 79952035065 scopus 로고    scopus 로고
    • Rescue of misfolded proteins and stabilization by small molecules
    • Stevens RC, Sancho J, Martinez A. 2010. Rescue of misfolded proteins and stabilization by small molecules. Methods Mol Biol 648:313–324.
    • (2010) Methods Mol Biol , vol.648 , pp. 313-324
    • Stevens, R.C.1    Sancho, J.2    Martinez, A.3
  • 40
    • 14844294424 scopus 로고    scopus 로고
    • Protein production by auto-induction in high density shaking cultures
    • Studier FW. 2005. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif 41:207–234.
    • (2005) Protein Expr Purif , vol.41 , pp. 207-234
    • Studier, F.W.1
  • 42
    • 33746578432 scopus 로고    scopus 로고
    • Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality
    • Thiel C, Lubke T, Matthijs G, von Figura K, Korner C. 2006. Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality. Mol Cell Biol 26:5615–5620.
    • (2006) Mol Cell Biol , vol.26 , pp. 5615-5620
    • Thiel, C.1    Lubke, T.2    Matthijs, G.3    von Figura, K.4    Korner, C.5
  • 44
    • 84862859338 scopus 로고    scopus 로고
    • Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation
    • Tomasic T, Peterlin Masic L. 2012. Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation. Expert Opin Drug Discov 7:549–560.
    • (2012) Expert Opin Drug Discov , vol.7 , pp. 549-560
    • Tomasic, T.1    Peterlin Masic, L.2
  • 45
    • 0029585865 scopus 로고
    • Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I
    • Van Schaftingen E, Jaeken J. 1995. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett 377:318–320.
    • (1995) FEBS Lett , vol.377 , pp. 318-320
    • Van Schaftingen, E.1    Jaeken, J.2
  • 46
    • 66749140994 scopus 로고    scopus 로고
    • Functional analysis of three splicing mutations identified in the PMM2 gene: toward a new therapy for congenital disorder of glycosylation type Ia
    • Vega AI, Perez-Cerda C, Desviat LR, Matthijs G, Ugarte M, Perez B. 2009. Functional analysis of three splicing mutations identified in the PMM2 gene: toward a new therapy for congenital disorder of glycosylation type Ia. Hum Mutat 30:795–803.
    • (2009) Hum Mutat , vol.30 , pp. 795-803
    • Vega, A.I.1    Perez-Cerda, C.2    Desviat, L.R.3    Matthijs, G.4    Ugarte, M.5    Perez, B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.